NRGene Overview

  • Founded
  • 2009

Founded
  • Status
  • Public

  • Employees
  • 55

Employees
  • Stock Symbol
  • NRGN

Stock Symbol
  • Share Price
  • $2.25

  • (As of Monday Closing)

NRGene General Information

Description

NRGene Technologies Ltd is engaged in the development of artificial intelligence-based software for the analysis of genetic information in order to improve species of plants and animals.

Contact Information

Website
www.nrgene.com
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Stock Exchange
TAE
Primary Office
  • 5 Golda Meir Street
  • Ness Ziona 7403649
  • Israel
+972 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NRGene Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.25 $2.27 $1.89 - $5.03 $28.1M 12.5M 9.7K -$0.61

NRGene Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 19,695 24,109
Revenue 3,801 4,463 7,035
EBITDA (6,376) (7,498) (1,745)
Net Income (7,612) (8,338) (3,146)
Total Assets 19,888 26,365 3,799
Total Debt 1,567 3,343 5,077
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NRGene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NRGene‘s full profile, request access.

Request a free trial

NRGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
NRGene Technologies Ltd is engaged in the development of artificial intelligence-based software for the analysis of gene
Biotechnology
Ness Ziona, Israel
55 As of 2021
0000
0000 0000-00-00
00000000 0000

000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
0000 000000000
Menlo Park, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000000000000 00000000
Boston, MA
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NRGene Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personalis Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
0000000 0000000 Formerly VC-backed Boston, MA 000 00000 000000&0 00000
000000 00000000 Formerly VC-backed Saint Sulpice, Switzerland 000 00000 000000000 00000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
00000 00000000 Venture Capital-Backed London, United Kingdom 000 0000 00000000000 0000
You’re viewing 5 of 5 competitors. Get the full list »

NRGene Executive Team (8)

Name Title Board Seat Contact Info
Gil Ronen Ph.D Co-Founder & Chief Executive Officer
Ehud Belder Chief Financial Officer
Richard Calk Chief Strategy Officer
You’re viewing 3 of 8 executive team members. Get the full list »

NRGene Board Members (1)

Name Representing Role Since
David Lieber NRGene Chairman 000 0000
To view NRGene’s complete board members history, request access »

NRGene Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial